Dr. Aaron Debon, Technology Platform Manager Bioconjugation

Aaron earned a master’s degree in interdisciplinary sciences before completing his PhD in organic chemistry at ETH Zürich, where his research focused on protein engineering. As a discovery fellow at Novartis, he specialized in enzymatic peptide modification and bioconjugation. At INOFEA, he serves as Technology Platform Manager Bioconjugation, leading the development and advancement of INOFEA’s enzymatic bioconjugation platform, driving enzyme engineering and application development, and translating customer needs into innovative, technically viable solutions.